卓爾智聯(02098.HK)附屬過去逾兩年購買多份理財產品未有及時披露
卓爾智聯(02098.HK)公布,於2018年8月16日至去年12月4日,附屬中農網集團及卓鋼鏈於業務經營過程中多次認購銀行發售之若干理財產品。集團管理層認為,認購事項乃於其日常及一般業務過程中進行,故將不會構成上市規則第14章項下之「交易」。因此,公司於相關時間未能遵守上市規則第14.34條項下之相關通知及公告規定。
公司表示,就未有遵守上市規則深表遺憾,惟強調鑒公司認為認購事項乃集團交易平台之日常運營過程之一部分,有關不合規事件屬無心之失。公司稱日後將就其認購理財產品嚴格遵守內部控制程序,並及時作出適當披露,以確保遵守上市規則。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.